Remmie, founded in 2018 and headquartered in Culver City, California, develops and manufactures smart, connected otoscopes designed to empower families and improve diagnostic accuracy for telemedicine companies. Their core mission is to enhance healthcare accessibility and accuracy by providing user-friendly medical devices that allow for home diagnostics and remote consultations. Remmie's flagship product, the Remmie 3, is an intelligent ear, nose, and throat scope that helps families avoid unnecessary trips to the doctor’s office.
Notable affiliated people include the founders and key investors who have supported Remmie's growth. The company has achieved significant milestones, including the successful launch of multiple product iterations and securing partnerships with telemedicine providers. Remmie's impact is evident in its contribution to reducing healthcare costs and improving patient outcomes through enhanced diagnostic tools.
